Inspira Technologies Oxy B.H.N. Ltd. (IINN)

NASDAQ: IINN · IEX Real-Time Price · USD
1.38
0.00 (0.00%)
At close: Sep 25, 2023, 12:00 AM
1.57
+0.19 (13.73%)
Pre-market: Sep 26, 2023, 9:03 AM EDT
Market Cap 17.40M
Revenue (ttm) n/a
Net Income (ttm) 19.60M
Shares Out 11.70M
EPS (ttm) -1.13
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 779
Open 1.40
Previous Close 1.38
Day's Range 1.35 - 1.48
52-Week Range 0.98 - 1.99
Beta 2.30
Analysts Strong Buy
Price Target 13.00 (+841.69%)
Earnings Date Nov 22, 2023

About IINN

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabi... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Jul 14, 2021
Employees 32
Stock Exchange NASDAQ
Ticker Symbol IINN
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for IINN stock is "Strong Buy" and the 12-month stock price forecast is $13.0.

Price Target
$13.0
(841.69% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization

Management estimates FDA clearance within approximately 6 months RA'ANANA, Israel , Sept. 13, 2023 /PRNewswire/ -- Inspira™ Technologies OXY BHN Ltd.

13 days ago - PRNewsWire

Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices

The extended agreement covers any European country RA'ANANA, Israel , Aug. 29, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira"), a...

4 weeks ago - PRNewsWire

Inspira™ Technologies Reports Second Quarter 2023 Financial Results

As of June 30, 2023, the Company had $8.9 million in cash, cash equivalents and short-term bank deposits. RA'ANANA, Israel , Aug. 10, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

6 weeks ago - PRNewsWire

INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.

RA'ANANA, Israel , Aug. 9, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute ...

6 weeks ago - PRNewsWire

Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval

RA'ANANA, Israel , July 24, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respirat...

2 months ago - PRNewsWire

Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.

Perfusion Solution, Inc. is a leading U.S.-based company that provides a platform of advanced medical devices, training and staffing to leading U.S. hospitals. RA'ANANA, Israel , July 19, 2023 /PRNews...

2 months ago - PRNewsWire

Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care

RA'ANANA, Israel , June 15, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute...

3 months ago - PRNewsWire

Inspira Technologies Appoints Dr. Nir as Chief Medical Officer

Dr. Nir is a clinical strategy expert with market experience RA'ANANA, Israel , May 30, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Insp...

4 months ago - PRNewsWire

Inspira™ Technologies Reports First Quarter 2023 Financial Results

As of March 31, 2023, the Company had $11.5 million in cash, cash equivalents, and short-term bank deposits RA'ANANA, Israel , May 18, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (Nasdaq...

4 months ago - PRNewsWire

Inspira™ Technologies will Reveal the New ALICE™ Device at the World's Largest Extracorporeal Life Support Conference

The ELSO conference is a consortium of healthcare institutions, researchers, and industry partners RA'ANANA, Israel , May 16, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) ...

4 months ago - PRNewsWire

Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide

Total addressable market is currently estimated at $1.16 billion RA'ANANA, Israel , May 11, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or ...

4 months ago - PRNewsWire

Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / May 5, 2023 / RedChip Companies will air new interviews with Inspira Technologies OXY B.H.N. Ltd. (Nasdaq:IINN, IINNW) and Genius Group Limited (NYSE American:GNS) on The Re...

Other symbols: GNS
5 months ago - Accesswire

Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas

RA'ANANA, ISRAEL / ACCESSWIRE / April 24, 2023 / Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute re...

5 months ago - Accesswire

Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results

As of December 31, 2022, the Company had $13.9 million in cash, cash equivalents, and deposits.  RA'ANANA, Israel , April 4, 2023 /PRNewswire/ -- Inspira Technologies OXY B.H.N.

6 months ago - PRNewsWire

Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study

First use of HYLA in a patient undergoing open-heart surgery at Sheba Medical Center in Israel RA'ANANA, Israel , March 22, 2023 /PRNewswire/ --  Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (...

6 months ago - PRNewsWire

Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor

The clinical study is planned for Q1-2023 to be performed on patients undergoing open-heart surgery at Sheba Medical Center RA'ANANA, Israel , Feb. 13, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B...

8 months ago - PRNewsWire

Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System's Convertible Dual Lumen Cannula Device and Method of Use

All 20 claims were found to be novel, with inventive step and industrial applicability RA'ANANA, Israel , Jan. 23, 2023 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: II...

8 months ago - PRNewsWire

Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular

Terumo Cardiovascular is a division of Terumo Corporation, a leading medical device company operating in 160+ countries and regions RA'ANANA, Israel, Dec. 28, 2022 /PRNewswire/ -- Inspira Technologies...

9 months ago - PRNewsWire

Inspira™ Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report®

ORLANDO, Fla, Dec. 22, 2022 /PRNewswire/ -- RedChip Companies will air an interview with Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"),...

9 months ago - PRNewsWire

Inspira(TM) Technologies Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / December 22, 2022 / RedChip Companies will air a new interview with Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (NASDAQ:IINNW) (the "Company" or "Inspira Technologie...

9 months ago - Accesswire

Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, ahead of planned 2023 FDA submission

RA'ANANA, Israel, Dec. 20, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support tech...

9 months ago - PRNewsWire

Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor

The agreement with Sheba Medical Center, 10th ranked hospital in the world*, to be the first site for the HYLA Blood Sensor's Clinical Study RA'ANANA, Israel , Dec. 14, 2022 /PRNewswire/ -- Inspira™ T...

10 months ago - PRNewsWire

Inspira™ Technologies Reports Third Quarter 2022 Financial Results

As of September 30, 2022, the Company had $16.2 million in cash, cash equivalents, and short-term bank deposits RA'ANANA, Israel , Nov. 23, 2022 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (N...

10 months ago - PRNewsWire

Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 for Deployment of 1,364 HYLA™ Blood Sensors

The agreement signed with Innovimed is over a 5-year period, subject to regulatory approvals RA'ANANA, Israel , Nov. 22, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASD...

10 months ago - PRNewsWire

InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System

RA'ANANA, Israel , Nov. 10, 2022 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (NASDAQ: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support te...

11 months ago - PRNewsWire